title: Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide.
abstract: METHODS
  Indium-111 activity concentrations in human tumor and normal tissue samples were determined at 24, 48 and 120 hr after i.v. injection of 111In-DTPA-D-Phe-1-octreotide. Fourteen patients were included in the study. Seven patients had medullary thyroid carcinoma, four had midgut carcinoid tumors, two had endocrine pancreatic tumors and one had chronic pancreatitis.
  
  
  RESULTS
  For midgut carcinoids, the tumor-to-blood ratio was 51:220, for medullary thyroid carcinoma 4:39, and for two endocrine pancreatic tumors 6 and 1500. Tumor-to-muscle ratios varied between 1 and 1200 and tumor-to-fat between 2 and 1500 depending on tumor type.
  
  
  CONCLUSIONS
  The sometimes extremely high tumor-to-normal tissue ratios present the possibility for use of radiolabeled octreotide for radiation therapy of somatostatin receptor positive tumors.
authors.affiliation: Department of Radiation Physics, University of Göteborg, Sahlgrenska Hospital, Sweden.
authors.forename: E
authors.initials: E
authors.lastname: Forssell-Aronsson
authors.forename: M
authors.initials: M
authors.lastname: Fjälling
authors.forename: O
authors.initials: O
authors.lastname: Nilsson
authors.forename: L E
authors.initials: LE
authors.lastname: Tisell
authors.forename: B
authors.initials: B
authors.lastname: Wängberg
authors.forename: H
authors.initials: H
authors.lastname: Ahlman
mesh_terms: D000008:Abdominal Neoplasms / Q000000981:diagnostic imaging; D000328:Adult; D000368:Aged; D002276:Carcinoid Tumor / Q000000981:diagnostic imaging; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007205:Indium Radioisotopes / Q000008:administration & dosage / Q000493:pharmacokinetics*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging* / Q000378:metabolism; D015282:Octreotide / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging; D010195:Pancreatitis / Q000000981:diagnostic imaging; D004369:Pentetic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D011877:Radionuclide Imaging; D017481:Receptors, Somatostatin / Q000378:metabolism; D012016:Reference Values; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging
chemical_list: D007205:Indium Radioisotopes; D017481:Receptors, Somatostatin; C071632:SDZ 215-811; D004369:Pentetic Acid; D015282:Octreotide